Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joerg Steinmann is active.

Publication


Featured researches published by Joerg Steinmann.


Fungal Diversity | 2014

Proposed nomenclature for Pseudallescheria, Scedosporium and related genera

Michaela Lackner; G. Sybren de Hoog; Liyue Yang; Leandro F. Moreno; Sarah Abdalla Ahmed; Fritz Andreas; Josef Kaltseis; Markus Nagl; Cornelia Lass-Flörl; Brigitte Risslegger; Günter Rambach; Cornelia Speth; Vincent Robert; Walter Buzina; Sharon C.-A. Chen; Jean-Philippe Bouchara; José F. Cano-Lira; Josep Guarro; Josepa Gené; Fabiola Fernández Silva; Rosa M. T. Haido; Gerhard Haase; Vladimír Havlíček; Dea Garcia-Hermoso; Jacques F. Meis; Ferry Hagen; Martin Kirchmair; Johannes Rainer; Katharina Schwabenbauer; Mirjam Zoderer

As a result of fundamental changes in the International Code of Nomenclature on the use of separate names for sexual and asexual stages of fungi, generic names of many groups should be reconsidered. Members of the ECMM/ISHAM working group on Pseudallescheria/Scedosporium infections herein advocate a novel nomenclature for genera and species in Pseudallescheria, Scedosporium and allied taxa. The generic names Parascedosporium, Lomentospora, Petriella, Petriellopsis, and Scedosporium are proposed for a lineage within Microascaceae with mostly Scedosporium anamorphs producing slimy, annellidic conidia. Considering that Scedosporium has priority over Pseudallescheria and that Scedosporium prolificans is phylogenetically distinct from the other Scedosporium species, some name changes are proposed. Pseudallescheria minutispora and Petriellidium desertorum are renamed as Scedosporium minutisporum and S. desertorum, respectively. Scedosporium prolificans is renamed as Lomentospora prolificans.


Gut | 2014

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells

Anggakusuma; Che C. Colpitts; Luis M. Schang; Heni Rachmawati; Anne Frentzen; Stephanie Pfaender; Patrick Behrendt; Richard J. P. Brown; Dorothea Bankwitz; Joerg Steinmann; Michael Ott; Philip Meuleman; Charles M. Rice; Alexander Ploss; Thomas Pietschmann; Eike Steinmann

Objective Hepatitis C virus (HCV) infection causes severe liver disease and affects more than 160 million individuals worldwide. People undergoing liver organ transplantation face universal re-infection of the graft. Therefore, affordable antiviral strategies targeting the early stages of infection are urgently needed to prevent the recurrence of HCV infection. The aim of the study was to determine the potency of turmeric curcumin as an HCV entry inhibitor. Design The antiviral activity of curcumin and its derivatives was evaluated using HCV pseudo-particles (HCVpp) and cell-culture-derived HCV (HCVcc) in hepatoma cell lines and primary human hepatocytes. The mechanism of action was dissected using R18-labelled virions and a membrane fluidity assay. Results Curcumin treatment had no effect on HCV RNA replication or viral assembly/release. However, co-incubation of HCV with curcumin potently inhibited entry of all major HCV genotypes. Similar antiviral activities were also exerted by other curcumin derivatives but not by tetrahydrocurcumin, suggesting the importance of α,β-unsaturated ketone groups for the antiviral activity. Expression levels of known HCV receptors were unaltered, while pretreating the virus with the compound reduced viral infectivity without viral lysis. Membrane fluidity experiments indicated that curcumin affected the fluidity of the HCV envelope resulting in impairment of viral binding and fusion. Curcumin has also been found to inhibit cell-to-cell transmission and to be effective in combination with other antiviral agents. Conclusions Turmeric curcumin inhibits HCV entry independently of the genotype and in primary human hepatocytes by affecting membrane fluidity thereby impairing virus binding and fusion.


The Journal of Infectious Diseases | 2013

Transmission of Hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment

Juliane Doerrbecker; Patrick Behrendt; Pedro Mateu-Gelabert; Sandra Ciesek; Nina Riebesehl; Corinne Wilhelm; Joerg Steinmann; Thomas Pietschmann; Eike Steinmann

BACKGROUND Hepatitis C virus (HCV) transmission among people who inject drugs remains a challenging public health problem. We investigated the risk of HCV transmission by analyzing the direct association of HCV with filters, water to dilute drugs, and water containers. METHODS Experiments were designed to replicate practices by people who inject drugs and include routinely used injection equipment. HCV stability in water was assessed by inoculation of bottled water with HCV. Viral association with containers was investigated by filling the containers with water, inoculating the water with HCV, emptying the water, and refilling the container with fresh water. Transmission risk associated with drug preparation filters was determined after drawing virus through a filter and incubating the filter to release infectious particles. RESULTS HCV can survive for up to 3 weeks in bottled water. Water containers present a risk for HCV transmission, as infectious virions remained associated with water containers after washing. Physical properties of the water containers determined the degree of HCV contamination after containers were refilled with water. HCV was also associated with filter material, in which around 10% of the viral inoculum was detectable. CONCLUSIONS This study demonstrates the potential risk of HCV transmission among injection drug users who share water, filters, and water containers and will help to define public health interventions to reduce HCV transmission.


Journal of Clinical Microbiology | 2012

Multiplex PCR for Rapid and Improved Diagnosis of Bloodstream Infections in Liver Transplant Recipients

Peter-Michael Rath; Fuat H. Saner; Andreas Paul; Nils Lehmann; Eike Steinmann; Jan Buer; Joerg Steinmann

ABSTRACT This prospective study evaluated the utility of the SeptiFast (SF) test in detecting 25 clinically important pathogens in 225 blood samples from 170 intensive care unit (ICU) patients with suspected sepsis after liver transplantation (LTX) or after other major abdominal surgery (non-LTX). SF yielded a significantly higher positivity rate in the LTX group (52.3%) than in the non-LTX group (30.5%; P = 0.0009). SF may be a powerful tool for the early diagnosis of bloodstream infections in LTX patients.


Journal of Clinical Microbiology | 2015

β-d-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Antonia Koltze; Peter Rath; Stefan Schöning; Joerg Steinmann; Thomas A. Wichelhaus; Peter Bader; Konrad Bochennek; Thomas Lehrnbecher

ABSTRACT While the assessment of β-d-glucan (BDG) levels in adults improves the early diagnosis of invasive fungal disease (IFD), data on BDG levels in children are limited. We therefore assessed in a prospective cohort study the value of serial BDG screening for early detection of IFD in children undergoing allogeneic hematopoietic stem cell transplantation (HSCT). IFD was defined according to the revised European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria, with the necessary modification that BDG was not included as a microbiological criterion. For the analysis, a total of 702 serum samples were obtained in 34 pediatric HSCT recipients. Proven IFD occurred in two patients (fusariosis and Candida sepsis, respectively), and probable invasive aspergillosis was diagnosed in four patients. Analyses including different cutoff values for BDG levels and different definitions of the onset of IFD demonstrated that the BDG assay has a relatively high sensitivity and good negative predictive value, whereas the positive predictive value has major limitations (<30%). Receiver operating characteristic analyses suggested an optimal cutoff between 60 and 70 pg/ml for different definitions of the onset of IFD. Our data show that BDG screening in pediatric HSCT recipients has a low positive predictive value and is therefore of limited usefulness.


The Journal of Infectious Diseases | 2013

Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk

Stephanie Pfaender; Julia Heyden; Martina Friesland; Sandra Ciesek; Asim Ejaz; Joerg Steinmann; Jochen Steinmann; Angelika Malarski; Heribert Stoiber; Georgios Tsiavaliaris; Werner Bader; Gerhard Jahreis; Thomas Pietschmann; Eike Steinmann

BACKGROUND Hepatitis C virus (HCV) is spread through direct contact with blood, although alternative routes of transmission may contribute to the global burden. Perinatal infection occurs in up to 5% of HCV-infected mothers, and presence of HCV RNA in breast milk has been reported. We investigated the influence of breast milk on HCV infectiousness. METHODS/RESULTS Human breast milk reduced HCV infectivity in a dose-dependent manner. This effect was species-specific because milk from various animals did not inhibit HCV infection. Treatment of HCV with human breast milk did not compromise integrity of viral RNA or capsids but destroyed the lipid envelope. Fractionation of breast milk revealed that the antiviral activity is present in the cream fraction containing the fat. Proteolytic digestion of milk proteins had no influence on its antiviral activity, whereas prolonged storage at 4°C increased antiviral activity. Notably, pretreatment with a lipase inhibitor ablated the antiviral activity and specific free fatty acids of breast milk were antiviral. CONCLUSIONS The antiviral activity of breast milk is linked to endogenous lipase-dependent generation of free fatty acids, which destroy the viral lipid envelope. Therefore, nursing by HCV-positive mothers is unlikely to play a major role in vertical transmission.


Immunology | 2014

Impact of 5-aza-2′-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells

Jan Kehrmann; Roman Tatura; Michael Zeschnigk; Michael Probst-Kepper; Robert Geffers; Joerg Steinmann; Jan Buer

The epigenetic regulation of transcription factor genes is critical for T‐cell lineage specification. A specific methylation pattern within a conserved region of the lineage specifying transcription factor gene FOXP3, the Treg‐specific demethylated region (TSDR), is restricted to regulatory T (Treg) cells and is required for stable expression of FOXP3 and suppressive function. We analysed the impact of hypomethylating agents 5‐aza‐2′‐deoxycytidine and epigallocatechin‐3‐gallate on human CD4+ CD25− T cells for generating demethylation within FOXP3‐TSDR and inducing functional Treg cells. Gene expression, including lineage‐specifying transcription factors of the major T‐cell lineages and their leading cytokines, functional properties and global transcriptome changes were analysed. The FOXP3‐TSDR methylation pattern was determined by using deep amplicon bisulphite sequencing. 5‐aza‐2′‐deoxycytidine induced FOXP3‐TSDR hypomethylation and expression of the Treg‐cell‐specific genes FOXP3 and LRRC32. Proliferation of 5‐aza‐2′‐deoxycytidine‐treated cells was reduced, but the cells did not show suppressive function. Hypomethylation was not restricted to FOXP3‐TSDR and expression of master transcription factors and leading cytokines of T helper type 1 and type 17 cells were induced. Epigallocatechin‐3‐gallate induced global DNA hypomethylation to a lesser extent than 5‐aza‐2′‐deoxycitidine, but no relevant hypomethylation within FOXP3‐TSDR or expression of Treg‐cell‐specific genes. Neither of the DNA methyltransferase inhibitors induced fully functional human Treg cells. 5‐aza‐2′‐deoxycitidine‐treated cells resembled Treg cells, but they did not suppress proliferation of responder cells, which is an essential capability to be used for Treg cell transfer therapy. Using a recently developed targeted demethylation technology might be a more promising approach for the generation of functional Treg cells.


Applied and Environmental Microbiology | 2015

Mechanisms of methods for hepatitis C virus inactivation.

Stephanie Pfaender; Janine Brinkmann; Daniel Todt; Nina Riebesehl; Joerg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann

ABSTRACT Virus inactivation by chemical disinfectants is an important instrument for infection control in medical settings, but the mechanisms involved are poorly understood. In this study, we systematically investigated the effects of several antiviral treatments on hepatitis C virus (HCV) particles as model for enveloped viruses. Studies were performed with authentic cell culture-derived viruses, and the influence of chemical disinfectants, heat, and UV treatment on HCV was analyzed by the determination of infectious particles in a limiting-dilution assay, by quantitative reverse transcription-PCR, by core enzyme-linked immunosorbent assay, and by proteolytic protection assay. All different inactivation methods resulted in a loss of HCV infectivity by targeting different parts of the virus particle. Alcohols such as ethanol and 2-propanol did not affect the viral RNA genome integrity but disrupted the viral envelope membrane in a capsid protection assay. Heat and UV treatment of HCV particles resulted in direct damage of the viral genome since transfection of viral particle-associated RNA into permissive cells did not initiate RNA replication. In addition, heat incubation at 80°C disrupted the HCV envelope, rendering the viral capsid susceptible to proteolytic digest. This study demonstrated the molecular processes of viral inactivation of an enveloped virus and should facilitate the development of effective disinfection strategies in infection control not only against HCV but also against other enveloped viruses.


Journal of Viral Hepatitis | 2013

Thermostability of seven hepatitis C virus genotypes in vitro and in vivo.

Juliane Doerrbecker; Philip Meuleman; Jonghoon Kang; Nina Riebesehl; Corinne Wilhelm; Martina Friesland; Stephanie Pfaender; Joerg Steinmann; Thomas Pietschmann; Eike Steinmann

Hepatitis C virus (HCV) is transmitted primarily through percutaneous exposure to contaminated blood especially in healthcare settings and among people who inject drugs. The environmental stability of HCV has been extrapolated from studies with the bovine viral diarrhoea virus or was so far only addressed with HCV genotype 2a viruses. The aim of this study was to compare the environmental and thermostability of all so far known seven HCV genotypes in vitro and in vivo. Incubation experiments at room temperature revealed that all HCV genotypes showed similar environmental stabilities in suspension with viral infectivity detectable for up to 28 days. The risk of HCV infection may not accurately be reflected by determination of HCV RNA levels. However, viral stability and transmission risks assessed from in vitro experiments correlated with viral infectivity in transgenic mice containing human liver xenografts. A reduced viral stability for up to 2 days was observed at 37 °C with comparable decays for all HCV genotypes confirmed by thermodynamic analysis. These results demonstrate that different HCV genotypes possess comparable stability in the environment and that noninfectious particles after incubation in vitro do not cause infection in an HCV in vivo model. These findings are important for estimation of HCV cross‐transmission in the environment and indicate that different HCV genotypes do not display an altered stability or resistance at certain temperatures.


Cell Host & Microbe | 2017

β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections

Heike Grassmé; Brian Henry; Regan Ziobro; Katrin Anne Becker; Joachim Riethmüller; Aaron Gardner; Aaron P. Seitz; Joerg Steinmann; Stephan Lang; Christopher Ward; Edward H. Schuchman; Charles C. Caldwell; Markus Kamler; Michael J. Edwards; Malcolm Brodlie; Erich Gulbins

Summary Chronic pulmonary colonization with bacterial pathogens, particularly Pseudomonas aeruginosa, is the primary cause of morbidity and mortality in patients with cystic fibrosis (CF). We observed that β1-integrins accumulate on the luminal membrane of upper-airway epithelial cells from mice and humans with CF. β1-integrin accumulation is due to increased ceramide and the formation of ceramide platforms that trap β1-integrins on the luminal pole of bronchial epithelial cells. β1-integrins downregulate acid ceramidase expression, resulting in further accumulation of ceramide and consequent reduction of surface sphingosine, a lipid that kills bacteria. Interrupting this vicious cycle by triggering surface β1-integrin internalization via anti-β1-integrin antibodies or the RGD peptide ligand—or by genetic or pharmacological correction of ceramide levels—normalizes β1-integrin distribution and sphingosine levels in CF epithelial cells and prevents P. aeruginosa infection in CF mice. These findings suggest a therapeutic avenue to ameliorate CF-associated bacterial infections.

Collaboration


Dive into the Joerg Steinmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jan Buer

University of Duisburg-Essen

View shared research outputs
Top Co-Authors

Avatar

Peter-Michael Rath

University of Duisburg-Essen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Todt

Ruhr University Bochum

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge